UNC Has Key Role in COVID-19 Drug Nearly Ready for Human Trials

Posted Apr 8, 2020
Scientists in Ralph Baric’s lab at UNC are playing a key role in the development and testing of a new drug, called EIDD-2801, that could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials. Baric is UNC’s Kenan Distinguished Professor of epidemiology. (Carolina Alumni Review)

Related: Campus Connections

Carolina Brewery Celebrates 30 Years
Few Tar Heels have a pedigree as lengthy as Robert Poitras, a fourth-generation UNC alum who grew up tailgating at Kenan Stadium and cheering on...
Sun Nov 9, 2025

Meet 10 Tar Heel military heroes
UNC has a longstanding history of supporting veterans on campus. Before or after they served their country, they spent time in Chapel Hill learning from...
Sat Nov 8, 2025

Video: IC Podcast - Touch 'Em All with Larry Keith
"Touch 'Em All: My Life and Career at Sports Illustrated" is Larry Keith's memoir about an accomplished writer and editor who began his career at...
Wed Nov 5, 2025

A guide to Chapel Hill's live music scene
Chapel Hill’s live music scene is bustling and evergreen. Music venues in Chapel Hill and Carrboro have shows almost every single night. Student musicians make...
Wed Nov 5, 2025